Figdor CG - Search Results

1

Dendritic cell-based nanovaccines for cancer immunotherapy.

Paulis LE, Mandal S, Kreutz M, Figdor CG. Paulis LE, et al. Among authors: figdor cg. Curr Opin Immunol. 2013 Jun;25(3):389-95. doi: 10.1016/j.coi.2013.03.001. Epub 2013 Apr 6. Curr Opin Immunol. 2013. PMID: 23571027 Review.

2

Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro.

Bakker AB, Marland G, de Boer AJ, Huijbens RJ, Danen EH, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: figdor cg. Cancer Res. 1995 Nov 15;55(22):5330-4. Cancer Res. 1995. PMID: 7585596

3

Dendritic cells in immune response induction.

Marland G, Bakker AB, Adema GJ, Figdor CG. Marland G, et al. Among authors: figdor cg. Stem Cells. 1996 Sep;14(5):501-7. doi: 10.1002/stem.140501. Stem Cells. 1996. PMID: 8888491 Review.

4

Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.

Schreurs MW, de Boer AJ, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: figdor cg. Cancer Res. 1998 Jun 15;58(12):2509-14. Cancer Res. 1998. PMID: 9635569

5

Dendritic cells: migratory cells that are attractive.

Lindhout E, Figdor CG, Adema GJ. Lindhout E, et al. Among authors: figdor cg. Cell Adhes Commun. 1998;6(2-3):117-23. doi: 10.3109/15419069809004467. Cell Adhes Commun. 1998. PMID: 9823462 Review.

6

Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.

Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, Figdor CG, Adema GJ. Eggert AA, et al. Among authors: figdor cg. Cancer Res. 1999 Jul 15;59(14):3340-5. Cancer Res. 1999. PMID: 10416590

7

Generation and functional characterization of mouse monocyte-derived dendritic cells.

Schreurs MW, Eggert AA, de Boer AJ, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: figdor cg. Eur J Immunol. 1999 Sep;29(9):2835-41. doi: 10.1002/(SICI)1521-4141(199909)29:09<2835::AID-IMMU2835>3.0.CO;2-Q. Eur J Immunol. 1999. PMID: 10508258 Free article.

8

[Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].

Punt CJ, de Vries IJ, Mulders PF, Adema GJ, Figdor CG. Punt CJ, et al. Among authors: figdor cg. Ned Tijdschr Geneeskd. 1999 Nov 27;143(48):2408-14. Ned Tijdschr Geneeskd. 1999. PMID: 10608974 Review. Dutch.

9

Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.

Schreurs MW, Eggert AA, Punt CJ, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: figdor cg. Crit Rev Oncog. 2000;11(1):1-17. Crit Rev Oncog. 2000. PMID: 10795625 Review.

10

DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.

Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, van Duijnhoven GC, Grabovsky V, Alon R, Figdor CG, van Kooyk Y. Geijtenbeek TB, et al. Among authors: figdor cg. Nat Immunol. 2000 Oct;1(4):353-7. doi: 10.1038/79815. Nat Immunol. 2000. PMID: 11017109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page